Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Condition:   Hidradenitis Suppurativa Intervention:   Drug: Guselkumab Sponsors:   Rockefeller University;   Janssen Scientific Affairs, LLC Not yet recruiting

Source: ClinicalTrials.gov - September 10, 2019 Category: Research Source Type: clinical trials